Importance of pH Homeostasis in Metabolic Health and Diseases: Crucial Role of Membrane Proton Transport

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Aoi, Wataru ^a   Marunaka, Yoshinori ^b,c  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Takatsuki city   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BUFFER; HEMOGLOBIN; MONOCARBOXYLATE TRANSPORTER; SODIUM; PROTON PUMP;

BINDING AFFINITY; BODY FLUID; CELL PH; DIETARY INTAKE; ENZYME PHOSPHORYLATION; EXERCISE; EXTRACELLULAR SPACE; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTERSTITIAL FLUID; LIVER; MEMBRANE TRANSPORT; METABOLIC DISORDER; MUSCLE CONTRACTION; NONHUMAN; POINT MUTATION; PROTEIN EXPRESSION; PROTON SODIUM EXCHANGE; PROTON TRANSPORT; REVIEW; SKELETAL MUSCLE; ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; CHEMISTRY; ELECTROLYTE BALANCE; METABOLISM; PH;

ANIMALS; CELL MEMBRANE; HOMEOSTASIS; HUMANS; HYDROGEN-ION CONCENTRATION; METABOLIC DISEASES; MODELS, BIOLOGICAL; PROTON PUMPS; WATER-ELECTROLYTE BALANCE; WATER-ELECTROLYTE IMBALANCE;

EID: 84930897577     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/598986     Document Type: Review

References (92)

1. C. K. Garcia, J. L. Goldstein, R. K. Pathak, R. G. W. Anderson, and M. S. Brown, "Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle, " Cell, vol. 76, no. 5, pp. 865-873, 1994.
2. A. P. Halestrap, "The monocarboxylate transporter familystructure and functional characterization, " IUBMB Life, vol. 64, no. 1, pp. 1-9, 2012.
3. R. C. Poole and A. P. Halestrap, "Transport of lactate and other monocarboxylates acrossmammalian plasma membranes, " The American Journal of Physiology-Cell Physiology, vol. 264, no. 4, part 1, pp. C761-C782, 1993.
4. G. Burckhardt, F. Di Sole, and C. Helmle-Kolb, "The Na+/H+ exchanger gene family, " Journal of Nephrology, vol. 15, supplement 5, pp. S3-S21, 2002.
5. S.-H. Loh, W.-H. Chen, C.-H. Chiang, et al., "Intracellular pH regulatory mechanism in human atrial myocardium: Functional evidence for Na+/H+ exchanger and Na+/HCO3 symporter, " Journal of Biomedical Science, vol. 9, no. 3, pp. 198-205, 2002.
6. B. Authier, J. P. Albrand, M. Decorps, H. Reutenauer, and A. Rossi, "Disruption of muscle energy metabolism due to intense ischaemic exercise: a 31P NMR study in rats, " Physiological Chemistry & Physics & Medical NMR, vol. 19, no. 2, pp. 83-93, 1987.
7. R. H. Fitts, "Cellular mechanisms of muscle fatigue, " Physiological Reviews, vol. 74, no. 1, pp. 49-94, 1994.
8. C. Juel, "Lactate/proton co-transport in skeletal muscle: regulation and importance for pH homeostasis, " Acta Physiologica Scand inavica, vol. 156, no. 3, pp. 369-374, 1996.
9. C. Juel, "Intracellular pH recovery and lactate efflux in mouse soleus muscles stimulated in vitro: the involvement of sodium/proton exchange and a lactate carrier, " Acta Physiologica Scand inavica, vol. 132, no. 3, pp. 363-371, 1988.
10. A. Bonen, S. K. Baker, and H. Hatta, "Lactate transport and lactate transporters in skeletal muscle, " Canadian Journal of Applied Physiology, vol. 22, no. 6, pp. 531-552, 1997.
11. C. Juel, "Regulation of cellular pH in skeletal muscle fiber types, studied with sarcolemmal giant vesicles obtained from rat muscles, " Biochimicaet Biophysica Acta, vol. 1265, no. 2-3, pp. 127-132, 1995.
12. M. S. Eledrisi, M. S. Alshanti, M. F. Shah, B. Brolosy, and N. Jaha, "Overview of the diagnosis and management of diabetic ketoacidosis, "The American Journal of theMedical Sciences, vol. 331, no. 5, pp. 243-251, 2006.
13. P. Fafournoux, C. Demigne, and C. Remesy, "Mechanisms involved in ketone body release by rat liver cells: Influence of pH and bicarbonate, " The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 252, no. 2, part 1, pp. G200-G208, 1987.
14. H. K. Metcalfe, J. P. Monson, S. G. Welch, and R. D. Cohen, "Inhibition of lactate removal by ketone bodies in rat liver. Evidence for a quantitatively important role of the plasma membrane lactate transporter in lactatemetabolism, " Journal of Clinical Investigation, vol. 78, no. 3, pp. 743-747, 1986.
15. D. A. Roth and G. A. Brooks, "Lactate transport is mediated by a membrane-bound carrier in rat skeletal muscle sarcolemmal vesicles, " Archives of Biochemistry and Biophysics, vol. 279, no. 2, pp. 377-385, 1990.
16. C. Juel, "Muscle lactate transport studied in sarcolemmal giant vesicles, " Biochimicaet Biophysica Acta-Biomembranes, vol. 1065, no. 1, pp. 15-20, 1991.
17. J. C. McDermott and A. Bonen, "Lactate transport by skeletal muscle sarcolemmal vesicles, " Molecular and Cellular Biochemistry, vol. 122, no. 2, pp. 113-121, 1993.
18. R. C. Poole and A. P. Halestrap, "Transport of lactate and other monocarboxylates acrossmammalian plasma membranes, " The American Journal of Physiology, vol. 264, part 1, no. 4, pp. C761-C782, 1993.
19. A. Bonen, M. Tonouchi, D. Miskovic, C. Heddle, J. J. Heikkila, and A. P. Halestrap, "Isof orm-specific regulation of the lactate transporters MCT1 and MCT4 by contractile activity, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 279, no. 5, pp. E1131-E1138, 2000.
20. G. A. Brooks, H. Dubouchaud, M. Brown, J. P. Sicurello, and C. E. Butz, "Role of mitochondrial lactate dehydrogenase and lactate oxidation in the intracellular lactate shuttle, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 3, pp. 1129-1134, 1999.
21. H. Pilegaard, G. Terzis, A. Halestrap, and G. Juel, "Distribution of the lactate/H+ transporter isof orms MCT1 and MCT4 in human skeletal muscle, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 276, no. 5, pp. E843-E848, 1999.
22. C. K. Garcia, M. S. Brown, R. K. Pathak, and J. L. Goldstein, "cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1, " Journal of Biological Chemistry, vol. 270, no. 4, pp. 1843-1849, 1995.
23. Y. Murakami, N. Kohyama, Y. Kobayashi, et al., "Functional characterization of human monocarboxylate transporter 6 (SLC16A5), " Drug Metabolism and Disposition, vol. 33, no. 12, pp. 1845-1851, 2005.
24. E. C. H. Friesema, S. Ganguly, A. Abdalla, J. E. Manning Fox, A. P. Halestrap, and T. J. Visser, "Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter, " Journal of Biological Chemistry, vol. 278, no. 41, pp. 40128-40135, 2003.
25. K. Suhre, S.-Y. Shin, A.-K. Petersen, et al., "Human metabolic individuality in biomedical and pharmaceutical research, " Nature, vol. 477, no. 7362, pp. 54-62, 2011.
26. W. E. Visser, E. C. H. Friesema, and T. J. Visser, "Minireview: thyroid hormone transporters: the knowns and the unknowns, " Molecular Endocrinology, vol. 25, no. 1, pp. 1-14, 2011.
27. S. Wakabayashi, M. Shigekawa, and J. Pouyssegur, "Molecular physiology of vertebrate Na+/H+ exchangers, " Physiological Reviews, vol. 77, no. 1, pp. 51-74, 1997.
28. J. Orlowski and S. Grinstein, "Diversity of the mammalian sodium/proton exchanger SLC9 gene family, " Pflugers Archiv European Journal of Physiology, vol. 447, no. 5, pp. 549-565, 2004.
29. M. Donowitz and C. M. Tse, "Molecular physiology of mammalian epithelial Na+/H+ exchangers NHE2 and NHE3, " Current Topics in Membranes, vol. 50, pp. 437-498, 2001.
30. I. A. Bobulescu and O. W. Moe, "Na+/H+ exchangers in renal regulation of acid-base balance, " Seminars in Nephrology, vol. 26, no. 5, pp. 334-344, 2006.
31. C. A. Wagner, O. Devuyst, S. Bourgeois, and N. Mohebbi, "Regulated acid-base transport in the collecting duct, " Pflugers Archiv, vol. 458, no. 1, pp. 137-156, 2009.
32. B. J. Harvey and J. Ehrenfeld, "Epithelial pH and ion transport regulation by proton pumps and exchangers, " Ciba Foundation Symposium, vol. 139, pp. 139-164, 1988.
33. S. Sumi, I. Mineo, N. Kono, T. Shimizu, K. Nonaka, and S. Tarui, "Decreases in hepatic fructose-2, 6-bisphosphate level and fructose-6-phosphate, 2-kinase activity in diabetic mice: a close relationship to the development of ketosis, " Biochemical and Biophysical Research Communications, vol. 120, no. 1, pp. 103-108, 1984.
34. G. Lemieux, M. R. Arand a, P. Fournel, and C. Lemieux, "Renal enzymes during experimental diabetes mellitus in the rat. Role of insulin, carbohydrate metabolism, and ketoacidosis, " Canadian Journal of Physiology and Pharmacology, vol. 62, no. 1, pp. 70-75, 1984.
35. J. Gil, J. Carreras, and R. Bartrons, "Effects of diabetes on fructose 2, 6-P2, glucose 1, 6-P2 and 6-phosphof ructo 2-kinase in rat liver, " Biochemical and Biophysical Research Communications, vol. 136, no. 2, pp. 498-503, 1986.
36. B. Rahman, H. P. Schneider, A. Broer, J. W. Deitmer, and S. Broer, "Helix 8 and helix 10 are involved in substrate recognition in the rat monocarboxylate transporter MCT1, " Biochemistry, vol. 38, no. 35, pp. 11577-11584, 1999.
37. N. Merezhinskaya, W. N. Fishbein, J. I. Davis, et al., "Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport, "Muscle&Nerve, vol. 23, no. 1, pp. 90-97, 2000.
38. W. N. Fishbein, "Lactate transporter defect: a new disease of muscle, " Science, vol. 234, no. 4781, pp. 1254-1256, 1986.
39. N. Merezhinskava and W. N. Fishbein, "Muscle monocarboxylate transporter (MCT1) mutations in 5 patients with red cell irbc lactate transport deficiency (LTD), " FASEB Journal, vol. 11, no. 9, article 656, 1997.
40. G. Py, K. Lambert, A. Perez-Martin, E. Raynaud, C. Prefaut, and J. Mercier, "Impaired sarcolemmal vesicle lactate uptake and skeletal muscle MCT1 and MCT4 expression in obese Zucker rats, " American Journal of Physiology: Endocrinology and Metabolism, vol. 281, no. 6, pp. E1308-E1315, 2001.
41. C. Juel, A. Honig, and H. Pilegaard, "Muscle lactate transport studied in sarcolemmal giant vesicles: dependence on fibre type and age, " Acta Physiologica Scand inavica, vol. 143, no. 4, pp. 361-365, 1991.
42. K. J. A. McCullagh and A. Bonen, "Reduced lactate transport in denervated rat skeletal muscle, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 268, no. 4, part 2, pp. R884-R888, 1995.
43. G. M. Reaven, C. Hollenbeck, C.-Y. Jeng, M. S. Wu, and Y.-D. I. Chen, "Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM, " Diabetes, vol. 37, no. 8, pp. 1020-1024, 1988.
44. W. Aoi, S. Hosogi, N. Niisato, et al., "Improvement of insulin resistance, blood pressure and interstitial pH in early developmental stage of insulin resistance in OLETF rats by intake of propolis extracts, " Biochemical and Biophysical Research Communications, vol. 432, no. 4, pp. 650-653, 2013.
45. N. Fogh-Andersen, B. M. Altura, B. T. Altura, and O. Siggaard-Andersen, "Composition of interstitial fluid, " Clinical Chemistry, vol. 41, no. 10, pp. 1522-1525, 1995.
46. K. Aukland and H. O. Fadnes, "Protein concentration of interstitial fluid collected from rat skin by a wick method, " Acta Physiologica Scand inavica, vol. 88, no. 3, pp. 350-358, 1973.
47. H. Hayata, H. Miyazaki, N. Niisato, N. Yokoyama, and Y. Marunaka, "Lowered extracellular pH is involved in the pathogenesis of skeletal muscle insulin resistance, " Biochemical and Biophysical Research Communications, vol. 445, no. 1, pp. 170-174, 2014.
48. M. Otsuki, T. Kitamura, K. Goya, et al., "Association of urine acidification with visceral obesity and themetabolic syndrome, " Endocrine Journal, vol. 58, no. 5, pp. 363-367, 2011.
49. N. M. Maalouf, M. A. Cameron, O. W. Moe, B. Adams-Huet, and K. Sakhaee, "Low urine pH: a novel feature of the metabolic syndrome, " Clinical Journal of the American Society of Nephrology, vol. 2, no. 5, pp. 883-888, 2007.
50. N. M. Maalouf, M. A. Cameron, O. W. Moe, and K. Sakhaee, "Metabolic basis for low urine pH in type 2 diabetes, " Clinical Journal of the American Society of Nephrology, vol. 5, no. 7, pp. 1277-1281, 2010.
51. W. R. Farwell and E. N. Taylor, "Serum bicarbonate, anion gap and insulin resistance in the National Health and Nutrition Examination Survey, " Diabetic Medicine, vol. 25, no. 7, pp. 798-804, 2008.
52. L.-O. Ohlson, B. Larsson, P. Bjorntorp, et al., "Risk factors for type 2 (non-insulin-dependent) diabetes mellitus: thirteen and one-half years of follow-up of the participants in a study of Swedishmen born in 1913, " Diabetologia, vol. 31, no. 11, pp. 798-805, 1988.
53. M. G. Packard and J. Goodman, "Factors that influence the relative use of multiplememory systems, " Hippocampus, vol. 23, no. 11, pp. 1044-1052, 2013.
54. Y. Marunaka, K. Yoshimoto, W. Aoi, S. Hosogi, and H. Ikegaya, "Low pH of interstitial fluid around hippocampus of the brain in diabetic OLETF rats, " Molecular and Cellular Therapies, vol. 2, article 6, 2014.
55. Z. Mirza, M. A. Kamal, A. M. Abuzenadah, et al., "Establishing genomic/transcriptomic links between alzheimers disease and type II diabetes mellitus by meta-analysis approach, " CNS & Neurological Disorders-Drug Targets, vol. 13, no. 3, pp. 501-516, 2013.
56. H. Dudek, S. R. Datta, T. F. Franke, et al., "Regulation of neuronal survival by the serine-threonine protein kinase Akt, " Science, vol. 275, no. 5300, pp. 661-665, 1997.
57. N. Rasgon and L. Jarvik, "Insulin resistance, affective disorders, and alzheimers disease: review and hypothesis, " The Journals of Gerontology A: Biological Sciences and Medical Sciences, vol. 59, no. 2, pp. 178-183, 2004.
58. E. Steen, B. M. Terry, E. J. Rivera, et al., "Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease: is this type 3 diabetes?" Journal of Alzheimer's Disease, vol. 7, no. 1, pp. 63-80, 2005.
59. G. P. Holloway, V. Bezaire, G. J. F. Heigenhauser, et al., "Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise, " Journal of Physiology, vol. 571, no. 1, pp. 201-210, 2006.
60. R. Wibom, E. Hultman, M. Johansson, K. Matherei, D. Constantin-Teodosiu, and P. G. Schantz, "Adaptation of mitochondrial ATP production in human skeletal muscle to endurance training and detraining, " Journal of Applied Physiology, vol. 73, no. 5, pp. 2004-2010, 1992.
61. N. S. Bradley, L. A. Snook, S. S. Jain, G. J. F. Heigenhauser, A. Bonen, and L. L. Spriet, "Acute endurance exercise increases plasma membrane fatty acid transport proteins in rat and human skeletal muscle, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 302, no. 2, pp. E183-E189, 2012.
62. Y. Susuki, O. Ito, H. Takahashi, and K. Takamatsu, "The effect of sprint training on skeletal muscle carnosine in humans, " International Journal of Sport and Health Science, vol. 2, pp. 105-110, 2004.
63. W. S. Parkhouse, D. C. McKenzie, P. W. Hochachka, and W. K. Ovalle, "Buffering capacity of deproteinized human vastus lateralismuscle, " Journal of Applied Physiology, vol. 58, no. 1, pp. 14-17, 1985.
64. P. G. Arthur, M. C. Hogan, D. E. Bebout, P. D. Wagner, and P. W. Hochachka, "Modeling the effects of hypoxia on ATP turnover in exercising muscle, " Journal of Applied Physiology, vol. 73, no. 2, pp. 737-742, 1992.
65. C. A. DeSouza, L. F. Shapiro, C. M. Clevenger, et al., "Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men, " Circulation, vol. 102, no. 12, pp. 1351-1357, 2000.
66. H. Dubouchaud, G. E. Butterfield, E. E. Wolfel, B. C. Bergman, and G. A. Brooks, "Endurance training, expression, and physiology of LDH, MCT1, and MCT4 in human skeletal muscle, " American Journal of Physiology: Endocrinology and Metabolism, vol. 278, no. 4, pp. E571-E579, 2000.
67. S. K. Baker, K. J. A. Mccullagh, and A. Bonen, "Training intensity-dependent and tissue-specific increases in lactate uptake and MCT-1 in heart and muscle, " Journal of Applied Physiology, vol. 84, no. 3, pp. 987-994, 1998.
68. A. Bonen, K. J. A. McCullagh, C. T. Putman, E. Hultman, N. L. Jones, and G. J. F. Heigenhauser, "Short-term training increases human muscle MCT1 and femoral venous lactate in relation to muscle lactate, " American Journal of Physiology: Endocrinology and Metabolism, vol. 274, no. 1, part 1, pp. E102-E107, 1998.
69. K. Narumi, A. Furugen, M. Kobayashi, S. Otake, S. Itagaki, and K. Iseki, "Regulation of monocarboxylate transporter 1 in skeletal muscle cells by intracellular signaling pathways, " Biological and Pharmaceutical Bulletin, vol. 33, no. 9, pp. 1568-1573, 2010.
70. W. Aoi, M. Tsuzuki, M. Fujie, S. Iwashita, and M. Suzuki, "Sustained voluntary climbing exercise increases erythrocyte monocarboxylate transporter 1 in rats, " Journal of Clinical Biochemistry and Nutrition, vol. 32, pp. 23-29, 2002.
71. W. Aoi, S. Iwashita, M. Fujie, and M. Suzuki, "Sustained swimming increases erythrocyte MCT1 during erythropoiesis and ability to regulate pH homeostasis in rat, " International Journal of Sports Medicine, vol. 25, no. 5, pp. 339-344, 2004.
72. M. S. Skelton, D. E. Kremer, E. W. Smith, and L. B. Gladden, "Lactate influx into red blood cells from trained and untrained human subjects, " Medicine and Science in Sports and Exercise, vol. 30, no. 4, pp. 536-542, 1998.
73. L. A. Rassanan, K. J. Lampinen, and A. R. Poso, "Responses of blood and plasma lactate and plasma purine concentrations to maximal exercise and their relation to performance in stand ardbred trotters, " The American Journal of Veterinary Research, vol. 56, no. 12, pp. 1651-1656, 1995.
74. T. Nagao, S. Meguro, T. Hase, et al., "A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes, " Obesity, vol. 17, no. 2, pp. 310-317, 2009.
75. F. Squadrito, H. Marini, A. Bitto, et al., "Genistein in the metabolic syndrome: results of a randomized clinical trial, " The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 8, pp. 3366-3374, 2013.
76. M. Yoshida, P. F. Jacques, J. B. Meigs, et al., "Effect of vitamin K supplementation on insulin resistance in older men and women, " Diabetes Care, vol. 31, no. 11, pp. 2092-2096, 2008.
77. Z. Asemi, M. Samimi, Z. Tabassi, H. Shakeri, and A. Esmaillzadeh, "Vitamin D supplementation affects serum highsensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women, " Journal of Nutrition, vol. 143, no. 9, pp. 1432-1438, 2013.
78. A. Ramel, A. Martinez, M. Kiely, G. Morais, N. M. Band arra, and I. Thorsdottir, "Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults, " Diabetologia, vol. 51, no. 7, pp. 1261-1268, 2008.
79. B. Vessby, M. Uusitupa, K. Hermansen, et al., "Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study, " Diabetologia, vol. 44, no. 3, pp. 312-319, 2001.
80. S. Bhuvaneswari and C. V. Anuradha, "Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice, " Canadian Journal of Physiology and Pharmacology, vol. 90, no. 11, pp. 1544-1552, 2012.
81. M. Takikawa, S. Inoue, F. Horio, and T. Tsuda, "Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of amp-activated protein kinase in diabetic mice, " Journal of Nutrition, vol. 140, no. 3, pp. 527-533, 2010.
82. E. L. Greene, B. A. Nelson, K. A. Robinson, and M. G. Buse, " β-Lipoic acid prevents the development of glucose-induced insulin resistance in 3T3-L1 adipocytes and accelerates the decline in immunoreactive insulin during cell incubation, " Metabolism: Clinical and Experimental, vol. 50, no. 9, pp. 1063-1069, 2001.
83. H.-S. Lee, H. J. Lee, and H. J. Suh, "Silk protein hydrolysate increases glucose uptake through up-regulation of GLUT 4 and reduces the expression of leptin in 3T3-L1 fibroblast, " Nutrition Research, vol. 31, no. 12, pp. 937-943, 2011.
84. Y.-Q. Wang and M.-H. Yao, "Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK, " Journal of Nutritional Biochemistry, vol. 20, no. 12, pp. 982-991, 2009.
85. J. Lindstrom, P. Ilanne-Parikka, M. Peltonen, et al., "Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study, " The Lancet, vol. 368, no. 9548, pp. 1673-1679, 2006.
86. Y. Plantinga, L. Ghiadoni, A. Magagna, et al., "Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients, " American Journal of Hypertension, vol. 20, no. 4, pp. 392-397, 2007.
87. M. Zureik, P. Galan, S. Bertrais, et al., "Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 8, pp. 1485-1491, 2004.
88. I. Eskurza, K. D. Monahan, J. A. Robinson, and D. R. Seals, "Ascorbic acid does not affect large elastic artery compliance or central blood pressure in young and older men, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 286, no. 4, pp. H1528-H1534, 2004.
89. M. N. Woods, C. A. Wanke, P.-R. Ling, et al., "Effect of a dietary intervention and n-3 fatty acid supplementation on measures of serum lipid and insulin sensitivity in persons with HIV, " The American Journal of Clinical Nutrition, vol. 90, no. 6, pp. 1566-1578, 2009.
90. M. L. Khalil, "Biological activity of bee propolis in health and disease, " sian Pacific Journal of Cancer Prevention, vol. 7, no. 1, pp. 22-31, 2006.
91. K. Yagi, S. Kim, H. Wanibuchi, T. Yamashita, Y. Yamamura, and H. Iwao, "Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats, " Hypertension, vol. 29, no. 3, pp. 728-735, 1997.
92. K. Kawano, T. Hirashima, S. Mori, and T. Natori, "OLETF (Otsuka Long-Evans Tokushima fatty) rat: a new NIDDM rat strain, " Diabetes Research and Clinical Practice, vol. 24, pp. S317-S320, 1994.